Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
endostatin collagenase 3 biotech NA drugbank Neoplasms[MeSHID:D009369]
Diabetic Retinopathy[MeSHID:D003930]
Age related macular degeneration[MeSHID:D008268]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 NA investigational unknown
endostatin 72 kda type iv collagenase biotech NA drugbank Neoplasms[MeSHID:D009369]
Diabetic Retinopathy[MeSHID:D003930]
Age related macular degeneration[MeSHID:D008268]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 NA investigational unknown
endostatin matrix metalloproteinase-9 biotech NA drugbank Neoplasms[MeSHID:D009369]
Diabetic Retinopathy[MeSHID:D003930]
Age related macular degeneration[MeSHID:D008268]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 NA investigational unknown
endostatin prolactin receptor NA Clinical trial target TTD , DGIDB Neoplasms[MeSHID:D009369]
Diabetic Retinopathy[MeSHID:D003930]
Age related macular degeneration[MeSHID:D008268]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 21.22 phase 2 unknown
endostatin focal adhesion kinase 1 biotech NA drugbank Neoplasms[MeSHID:D009369]
Diabetic Retinopathy[MeSHID:D003930]
Age related macular degeneration[MeSHID:D008268]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 NA investigational unknown
endostatin e-selectin biotech NA drugbank Neoplasms[MeSHID:D009369]
Diabetic Retinopathy[MeSHID:D003930]
Age related macular degeneration[MeSHID:D008268]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 NA investigational unknown
click here to return to the previous page